Medical devices employing triazine compounds and compositions thereof

1. A stent comprising a compound disposed on or within the stent, the compound having the following formula:

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof; wherein:

R 1a is selected from

R 2a is selected from

R 3a is selected from —H,

R 4a is selected from —H or —CH 3 ;

R 5a is selected from

R 6a is selected from —H or —CH 3 ; and

R 7a is selected from.

2. A stent according to claim 1 , wherein the compound of formula Ia is:

N-Cycloheptyl-N′-(3-iodo-4-methoxyphenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(4-methoxy-3-nitro-phenyl)-N″-methyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; 5-{4-Cycloheptylamino-6-[methyl-(1methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-methoxy-benzonitrile; N-Cycloheptyl-N′-(4-ethoxy-3-fluoro-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-propoxy-phenyl)-N″-methyl-N″-(1-methylpiperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-isopropoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-ethoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-propoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methylpiperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-isopropoxy-phenyl)-N-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(4-methoxy-3-trifluoromethyl-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-benzyl)-N″-methyl-N″-(1-methylpiperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-benzyl)-N′-cycloheptyl-N″-methyl-N″-(1-methylpiperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-[2-(3-fluoro-4-methoxy-phenyl)-ethyl]-N″-methyl-N″(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-[2-(3-Chloro-4-methoxy-phenyl)-ethyl]-N′-cycloheptyl-N″-methyl-N″(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-trifluoromethyl-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl )-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-benzyl)-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-benzyl)-N″-methyl-N″-piperidin4-yl-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N′,N″-dimethyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(4-methylcyclohexyl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-cyclohexyl-N″-(3-fluoro-4-methoxy-phenyl)-N′,N″-dimethyl-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N′, N″-dimethyl-N″-(1-methyl-piperidin-3-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N′,N″-dimethyl-N″-piperidin-3-yl-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N′,N″-dimethyl-N″-(1-methyl-1,4-dihydro-pyridin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N′,N″-dimethyl-N″-pyridin-4-yl-[1,3,5]triazine-2,4,6-triamine; 4-({4-Cycloheptylamino-6-[(3-fluoro-4-methoxy-phenyl)-methyl-amino]-[1,3,5]triazin-2-yl}-methyl-amino)-1methyl-pyridinium, chloride; Acetic acid 4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenyl ester; N-Cycloheptyl-N′-(5-fluoro-6-methoxy-pyridin-3-yl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(4-fluoro-5-methoxy-pyridin-2-yl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(4-methylpiperidin-1-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-methyl-N′-(1-methyl-piperidin-4-yl)-N″-(4-trifluoromethoxy-3-trifluoromethyl-phenyl)-[1,3,5]triazine-2,4,6-triamine; N-(4-Amino-3-fluoro-phenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-y)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methylamino-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(4-dimethylamino-3-fluoro-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; 6-(3-Chloro-4-methylamino-phenoxy)-N-cycloheptyl-N′-methyl-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine; N-(3-Chloro-4-dimethylamino-phenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-6-(3-fluoro-4-methoxy-phenoxy)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine; 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N′-methyl-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N,N″-dimethyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cyclohept-4-phenyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methyl-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(4-ethyl-3-fluorophenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-cyclohexyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5 ]triazine-2,4,6-triamine; N-Cyclohept-3-enyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N,N″-dimethyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; 4-{4-Cycloheptylamino-6-[methyl-(1methyl-piperidin-4-yl)-amino]-[1,3,5triazin-2-ylamino}-2-fluoro-phenol; Sodium; 4-{4-(1-ethyl-hexylamino)-6-[methyl-(1-methyl-piperidin-4-yl)amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenolate; N-Cyclohept-2-enyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; 2-Chloro-4-[4-cycloheptylamino-6-(1-methyl-piperidin-4-ylamino)-[1,3,5]triazin-2-ylamino]-phenol; 4-[4-Cycloheptylamino-6-(1-methyl-piperidin-4-ylamino)-[1,3,5]triazin2-ylamino]-2-fluoro-phenol; N-(3-Chloro-4-methoxy-phenyl)-N′-cyclohept-2-enyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-piperidin-4-yl-[1,3,5]triazine-2,4,6-triamine; N-(3-Bromo-4-methoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; 4-[4-Cycloheptylamino-6-(methyl-piperidin-4-yl-amino)-[1,3,5]triazin-2-ylamino]-2-fluoro-phenol; 2-Chloro-4-[4-cycloheptylamino-6-(methyl-piperidin-4-yl-amino)-[1,3,5]triazin-2-ylamino]-phenol; Sodium; 2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-phenolate; N-(3-Chloro-4-methoxymethoxy-phenyl-N′-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; Phosphoric acid mono-(2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-phenoxymethyl) ester; Monosodium salt, phosphoric acid mono-(2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino-[1,3,5]triazine-2-ylamino)-phenoxymethyl) ester; N-(3-Chloro-4-methylsulfanylmethoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; Phosphoric acid di-tert-butyl ester 2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-phenoxymethyl ester; N-Cycloheptyl-N′-(3-fluoro-4-methoxymethoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; Phosphoric acid dibenzyl ester 2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]1,3,5]triazin-2-ylamino}-phenoxymethyl ester; Phosphoric acid mono-(4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenoxymethyl) ester; 2-(2-{2-[2-(2-Chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3, 5]triazin-2-ylamino}-phenoxy)-ethoxy]-ethoxyl -ethoxy)-ethanol; 2-(2-{2-[2-(4-{4-Cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenoxy)-ethoxy]-ethoxy}-ethoxy)-ethanol; 4-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino)-1-methyl-1-phosphonooxymethyl-piperidinium, chloride; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-pyridin-4yl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-pyridin-4yl-[1,3,5]triazine-2,4,6-triamine; Phosphoric acid mono-(4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenyl) ester; Phosphoric acid mono-(4-{[4-cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-methyl-amino}-piperidin-1-ylmethyl) ester; 4-{[4-Cycloheptylamino-6-(3-fluoro4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-methyl-amino)-1-methyl-1-phosphonooxymethyl-piperidinium, chloride; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-pyridin-4-yl-[1,3,5]triazine-2,4,6-triamine; 4-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptyl amino-[1,3,5]triazin-2-yl]-methyl-amino}-1-methyl-pyridinium, chloride; 4-{[4-Cycloheptylamino-6-(3-fluoro4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-methyl-amino}-1,1-di methyl-piperidinium, iodide; N-Allyl-N′-(3-chloro-4-methoxy-phenyl )-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-N″-propyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Fluoro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-N″-propyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-(3-methylamino-propyl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(3-dimethylamino-propyl)-N″-methyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(3-dimethylamino-propyl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-dimethylamino-propyl)-N″-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4,6-triamine; 6-Azepan-1-yl-N-(3-chloro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-methoxymethyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-piperidin-1-yl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(1-ethyl-piperidin-4yl)-N″-methyl-[1,3,5]triazine-2,4,6-triamine; 4-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino)-piperidine-1-carbaldehyde; 4-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino)-cyclohexanol; N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-[1,3,5]triazine-2,4,6-triamine; N-Bicyclo[2.2.2]oct-2-yl-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-[1,3,5]triazine-2,4,6-triamine; N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-N′-cycloheptyl-N″-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4,6-triamine; N-Bicyclo[2.2.2]oct-2-yl-N′-cycloheptyl-N″-(3-flouro-4-methoxy-phenyl-[1,3,5]triazine-2,4,6-triamine; N-Bicyclo[2.2.1]hept-2-yl-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptylidene-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(4-Amino-cyclohexyl)-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-N-methyl-[1,3,5]triazine-2,4,6-triamine; N-(4-Amino-cyclohexyl)-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl[1,3,5]triazine-2,4,6-triamine; 3-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino)-cyclohexanol; 3-{[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-methyl-amino)-cyclohexanol; N-(3-Amino-cyclohexyl)-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-N-methyl-[1,3,5]triazine-2,4,6-triamine; N-(4-Amino-cyclohexyl)-N′-cycloheptyl-N″-(3-fluoro-4-methoxy-phenyl)-N-methyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(4-dimethylamino-cyclohexyl)-N″-methyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(4-methoxy-cyclohexyl-N″-methyl-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-(4-methoxy-cyclohexyl-N″-methyl-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(4-dimethylamino-cyclohexyl)-[1,3,5]triazine-2,4,6-triamine; 4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-cyclohexanethiol; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(4-methylsulfanyl-cyclohexyl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(4-methanesulfonyl-cyclohexyl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-(4-methanesulfonyl-cyclohexyl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-N″-thiepan-4-yl-[1,3,5]triazine-2,4,6-triamine; 6-(Bicyclo[2.2.1]hept-2-yloxy)-N-(3-chloro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine; N-(3-Chloro-4-methoxy-phenyl)-N′-(1,1-dioxo-1lambda*6*-thiepan-4-yl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(1,1-Dioxo-1-lambda*6*-thiepan-4-yl)-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-N″-thiepan-3-yl-[1,3,5]triazine-2,4,6-triamine; 5-{[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-methyl}-thiazolidine-2,4-dione; 5-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-methyl)-thiazolidine2,4-dione; 5-{[4-Cycloheptylamino-6-(3-fluoro-4-hydroxy-phenylamino)-[1,3,5]triazin-2-ylamino]-methyl}-thiazolidine-2,4-dione; 5-{[4-(3-Chloro-4-hydroxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-methyl}-thiazolidine-2,4-dione; 6-(Bicyclo[2.2.1]hept-2-yloxy)-N-(3-fluoro-4-methoxy-phenyl)-N′-methyl-N′-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine; 4-[4-Cycloheptylamino-6-(hydroxymethyl-amino)-[1,3,5]triazin-2-ylamino]-2-fluoro-phenol; 5-({4-(3-Fluoro-4-methoxy-phenylamino)-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-methyl)-thiazolidine-2,4-dione; Sodium, 4-[4-cycloheptylamino-6-(pyrrolidine-2-carbonyloxy)-[1,3,5]triazin-2-ylamino]-2-fluoro-phenolate; N-Cycloheptyl-N′-(2,3-dihydro-1H-indol-2-ylmethyl)-N″-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4,6-triamine; 4-[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-cyclohexanethiol; 2-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino)-cyclohexanol; N-(2-Amino-cyclohexyl)-N′-(3-chloro-4-methoxy-phenyl)-N″-cycloheptyl-N-methyl-[1,3,5]triazine-2,4,6-triamine; N-(2-Amino-cyclohexyl)-N′-cycloheptyl-N″-(3-fluoro-4-methoxy-phenyl)[1,3,5]triazine-2,4,6-triamine; 4-[4-(2-Amino-cyclohexylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-2-fluoro-phenol; 2-[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-cyclohexanol; N-(3-Fluoro-4-methoxy-phenyl)-N′-(2-methyl-cyclohexyl)-N″-(1-methyl-hexyl)-[1,3,5]triazine-2,4,6-triamine; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-(3-methyl-cyclohexyl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(3-methyl-cyclohexyl)-[1,3,5]triazine-2,4,6-triamine; 3-(2-{2-[2-(2-Hydroxy-ethoxy)-ethoxoy]-ethoxy}-ethoxy)-propionic acid 4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenylester; 3-(2-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-propionic acid 4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin4-yl)-amino]-[1,3,5]triazin-2-ylamino)-2-fluoro-phenyl ester; 3-(2-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-propionic acid 2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-phenyl ester; 3-(2-{2-[2-(2-Hydroxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-propionic acid 2-chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-phenylester; 1-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-piperidin-1-yl)-3-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]ethoxy)-ethoxy)-propan-1-one; 1-{4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-piperidin-1-yl)-3-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]ethoxy}-ethoxy)-propan-1-one; 1-{4-[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-piperidin-1-yl}-3-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]ethoxy}-ethoxy)-propan-1-one; 1-{4-[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-piperidin-1-yl}-3-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]ethoxy}-ethoxy)-propan-1-one; 4-[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-1-{2-[2-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-ethoxy]-ethyl)-1-methyl-piperidinium, chloride; 4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-1-{2-[2-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-ethoxy]-ethyl}-1-methyl-piperidinium, chloride; 4-[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-1-{2-[2-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-ethoxy]-ethyl)-1-methyl-piperidinium, chloride; 4-[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-ylamino]-1-{2-[2-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-ethoxy]-ethyl)-1-methyl-piperidinium, chloride; 5-{4-Cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-2-methoxy-benzoic acid; 5-{4-Cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino)-2-methoxy-benzoic acid ethyl ester; Sodium, 5-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-methoxy-benzoate; 4-{[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-methyl-amino)-1-methyl-piperidinium, chloride; 4-{[4-Cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]-methyl-amino)-1-methyl-piperidinium, bromide; 4-{[4-(3-Chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino)-1-methyl-piperidinium, bromide; 3-Carboxy-propionate-4-{[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino}-1-methyl-piperidinium; 3-Carboxy-acrylate4-{[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino}-1-methyl-piperidinium; Carboxy-methanecarboxylate-4-{[4-(3chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]methyl-amino}-1-methyl-piperidinium; Carboxy-methanecarboxylate4-{[4-cycloheptylamino-6-(3-fluoro-4-methoxy-phenylamino)-[1,3,5]triazin-2-yl]methyl-amino)-1-methyl-piperidinium; 3-Carboxy-acrylate-4-{[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-yl]-methyl-amino}-1-methyl-piperidinium; 4-[4-(3-Chloro-4-hydroxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazin-2-ylamino]-piperidinium, chloride; 4-[4-Cycloheptylamino-6-(3-fluoro-4-hydroxy-phenylamino)-[1,3,5]triazin-2-ylamino]-piperidinium, chloride; 4-{4-Cycloheptylamino-6-[1-(4-methoxy-benzyl)-piperidin-4-ylamino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenol; 4-[4-Cycloheptylamino-6-(piperidin-4-ylamino)-[1,3,5]triazin-2-ylamino]-2-fluoro-phenol; 4-[4-Cyclopropylamino-6-(piperidine-4-ylamino)-[1,3,5]triazin-2-ylamino]-2-fluoro-phenol; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-methyl-N″-(1-methyl-1-oxy-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-methyl-N″-(-methyl 1-oxy-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; 4-{4-Cycloheptylamino-6-[methyl-(1-methyl-1-oxy-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-2-fluoro-phenol; 2-Chloro-4-{4-cycloheptylamino-6-[methyl-(1-methyl-1-oxy-piperidin-4-yl)-amino]-[1,3,5]triazin-2-ylamino}-phenol; N-Cycloheptyl-N′-(3-fluoro-4-methoxy-phenyl)-N″-(1-methanesulfonyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; N-(3-Chloro-4-methoxy-phenyl)-N′-cycloheptyl-N″-(1-methanesulfonyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine; or any combination thereof.

3. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 1 .

4. A stent according to claim 3 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or any combination thereof.

5. A stent comprising a compound disposed on or within the stent, the compound having the following formula:

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof; wherein:

G is NH or NMe;

E is N or CH;

X 1 is selected from m-F, m-Cl, m-Br, m-I, m-NO 2 , m-CN, m-CF 3 , m-C(O)OEt, or m-C(O)ONa;

X 2 is selected from p-OCH 3 , p-OEt, p-O-n-Pr, p-O-i-Pr, p-OCF 3 , p-OC(O)Me, p-NH 2 , p-NHMe, p-NMe 2 , p-Me, p-Et, p-OH, p-ONa, p-OP(O)(OH) 2 , p-OCH 2 OP(O)(OH) 2 , p-OCH 2 OP(O)(OH)(ONa), p-OCH 2 OP(O)(O-t-Bu) 2 , p-OCH 2 OP(O)(OCH 2 Ph) 2 , p-OCH 2 SMe, p-OCH 2 OMe, p-O(CH 2 CH 2 O) 3 CH 2 CH 2 OH, p-OC(O)(CH 2 CH 2 O) 4 CH 2 CH 2 OH, or p-OC(O)(CH 2 CH 2 O) 4 CH 2 CH 2 OMe,

R 1 is H;

z is 0, 1, or 2;

either: a) A is NH or NMe, and Y 1 is selected from

or b) AY 1 in combination is selected from

 and

either: a) D is NH, NMe, or O, and Y 2 is selected from —H,

or b) DY 2 in combination is selected from

6. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 5 .

7. A stent according to claim 6 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or any combination thereof.

8. A stent comprising a compound disposed on or within the stent, the compound having the following formula:

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof; wherein:

R 1a is selected from

R 6a is selected from H or Me;

R x is selected from

wherein R 2a is selected from H or Me; and

R 3a is selected from H,

9. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 8 .

10. A stent according to claim 9 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or any combination thereof.

11. A stent comprising a compound disposed on or within the stent, the compound having the following formula:

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof; wherein:

R 1a is selected from

R 7a is selected from

wherein R 4a is selected from H or Me; and

R 5a is selected from

12. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 11 .

13. A stent according to claim 12 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or

any combination thereof.

14. A stent comprising a compound disposed on or within the stent, the compound having the following formula:

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof; wherein:

R 1a is selected from,

R 2a is selected from

R 3a is selected from —H

R 5a is selected from

R 6a is selected from —H or —CH 3 .

15. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 14 .

16. A stent according to claim 15 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or

any combination thereof.

17. A stent comprising a compound disposed on or within the stent, wherein the compound is selected from:

4-benzyloxy-3-chloro-phenylamine,

N-(4-benzyloxy-3-chloro-phenyl)-N′-cycloheptyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine,

N-(4-benzyloxy-3-chloro-phenyl)-N′-cycloheptyl-N″-methyl-N″-piperidin4-yl-[1,3,5]triazine-2,4,6-triamine,

4-[4-cycloheptylamino-6-(methyl-piperidin-4-yl-amino)-[1,3,5]triazin-2-ylamino]-phenol,

4-{4-cycloheptylamino-6-[methyl-(1-methyl-piperidin-4-yl)-amino]-1,3,5]triazin-2-ylamino}-phenol,

2-chloro-4-(4,6-dichloro-[1,3,5]triazin-2-ylamino)-phenol,

2-chloro-4-(4-chloro-6-cycloheptylamino-[1,3,5]triazin-2-ylamino)-phenol,

N-(1-benzyl-piperidin-4-yl)-N′-(3-fluoro-4-methoxy-phenyl)-N″-cycloheptyl-[1,3,5]triazine-2,4,6-diamine,

N-cycloheptyl-N′-(4-methoxy-phenyl)-N″-piperidin-4-yl-[1,3,5]triazine-2,4,6-triamine,

6-chloro-N-cyclopropyl-N′-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4-diamine,

N-cyclopropyl-N′-(3-flouro-4-methoxy-phenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine,

N-cyclopropyl-N′-(1-ethyl-pyrrolidin-2-ylmethyl)-N″-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4,6-triamine,

6-chloro-N-(3-chloro-4-methoxypheny 1)-N′-cyclopropyl-[1,3,5]triazine-2,4-diamine,

N-cyclopropyl-N′-(3-chloro-4-methoxyphenyl)-N″-methyl-N″-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4,6-triamine,

6-chloro-N,N′-bis-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4-diamine, N-(1-ethyl-pyrrolidin-2-ylmethyl)-N′,N″-bis-(3-fluoro-4-methoxy-phenyl)-[1,3,5]triazine-2,4,6-triamine,

1-[4-(3-chloro-4-methoxyanilino)-cycloheptyl amino-1,3,5-triazin-2-yl]-2-azoloamymethanol,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(4-methylpiperzino)-1,3,5-triazine-4,2-diamine,

3-[4-(3-chloro-4-methoxyanilino)-6-cycloheptylamino-1,3,5-triazin-2-yloxy]-2-ethyl-4H-4-pyranone,

1-[3-{4-(3-chloro-4-methoxyanilino)-6-cycloheptylamino-1,3,5-triazine-2-yloxy}piperidino]-1-ethanone,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-isopropoxy-1,3,5-triazine-2,4-diamine,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(2-azolanylmethoxy)-1,3,5-triazine-2,4-diamine,

1-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazine-2-yl]-piperidin-3-ol],

1-[4-(3-chloro-4-methoxy-phenylamino)-6-cycloheptylamino-[1,3,5]triazine-2-yl]-piperidin-4-ol],

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(1-methyl-2-azolanylmethoxy)-1,3,5-triazine-2,4-diamine,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(1-methyl-4-piperidyloxy)-1,3,5-triazine-2,4-diamine,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(1,4-thiazinan-4-yl)-1,3,5-triazine-4,2-diamine,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(2-fluorophenoxy)-1,3,5-triazine-4,2-diamine,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-[2-(2-fluorophenoxy)ethoxy]-1,3,5-triazine-4,2-diamine,

N 2 -(3-chloro-4-methoxyphenyl)-N 4 -cycloheptyl-6-(6-methyl-2-pyryl methoxy]-1,3,5-triazine-4,2-diamine,

N-(3-chloro-4-methoxyphenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl piperidin-4-yl)[1,3,5]triazine-2,4,6-triamine,

N-(3-chloro-4-methoxyphenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl piperidin-4-yl)[1,3,5]triazine-2,4,6-triamine, HCl salt,

6-methoxy-N-(3-Chloro-4-methoxy phenyl)-N′-cycloheptyl-[1,3,5]triazine-2,4 diamine,

6-ethoxy-N-(3-Chloro-4-methoxy phenyl)-N′-cycloheptyl-[1,3,5]triazine-2,4diamine,

6-isopropoxy-N-(3-Chloro-4-methoxy phenyl)-N′-cycloheptyl-[1,3,5]triazine-2,4 diamine,

N-(3-chloro-4-methoxyphenyl)-N′-cycloheptyl-N″-methyl-N″-(1-methyl piperidin-4-yl)[1,3,5]triazine-2,4,6-triamine,

6-chloro-N-(3-chloro-4-methoxy-phenyl1)-N′-cycloheptyl-[1,3,5]triazine-2,4-diamine,

(3-chloro-4-methoxy-phenyl)-(4,6-dichloro-[1,3,5]triazin-2-yl)-amine,

6-Chloro-N-(3-fluoro-4-methoxy-phenyl)-N′-cycloheptyl-[1,3,5]triazine-2,4-diamine, or

(3-fluoro-4-methoxy-phenyl)-(4,6-dichloro-[1,3,5]triazin-2-yl)-amine;

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof.

18. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 17 .

19. A stent according to claim 18 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or

any combination thereof.

20. A stent comprising a compound disposed on or within the stent, wherein the compound is selected from:

or a stereoisomer, an enantiomer, a diastereomer, a racemic mixture, a salt, or any combination thereof.

21. A stent comprising a composition disposed on or within the stent, the composition comprising a pharmaceutically acceptable carrier and a compound according to claim 20 .

22. A stent according to claim 21 , wherein the composition further comprises at least one of the following:

a pharmaceutically acceptable auxiliary;

a pharmaceutically acceptable preservative;

a pharmaceutically acceptable excipient; or

any combination thereof.